Suresh Srivastava, a longtime researcher at Brookhaven, was recently selected as the new president-elect of the World Association of Radiopharmaceutical Molecular Therapy, or WARMTH.
WARMTH is an international organization with 400 members that include nuclear medicine physicians, radiochemists, physicists, and oncologists from more than 50 countries. Its members work to advance science and education relating to therapeutic nuclear medicine and radiopharmaceutical therapy for the benefit of public health around the world.
At Brookhaven, Srivastava, a pioneer in developing personalized medicine – customized, low-dose methods to fight cancer and other life-threatening diseases, heads the Medical Isotope Research and Production Program. He and his collaborators use the Brookhaven Linac Isotope Producer (BLIP) to create radioisotopes not available commercially for the nuclear medicine community and industry for treatments and research.
2013-3773 INT/EXT | Media & Communications Office
This is a print-friendly version of this feature. To see the full content, go to: